Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
1.730
+0.010 (0.58%)
Nov 21, 2024, 4:00 PM EST - Market closed
Ventyx Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 122 | 146 | 1,857 | 999 | - | - |
| Market Cap Growth | -92.47% | -92.15% | 85.92% | - | - | - |
| Enterprise Value | -142 | -143 | 1,446 | 1,081 | - | - |
| Last Close Price | 1.72 | 2.47 | 32.79 | 19.86 | - | - |
| PB Ratio | 0.44 | 0.60 | 5.25 | 3.58 | - | - |
| P/TBV Ratio | 0.55 | 0.60 | 5.25 | 3.58 | - | - |
| Debt / Equity Ratio | 0.04 | 0.05 | 0.00 | - | -0.41 | -0.93 |
| Quick Ratio | 22.37 | 11.33 | 19.44 | 21.05 | 0.17 | 0.49 |
| Current Ratio | 23.52 | 11.87 | 20.21 | 21.41 | 0.17 | 0.55 |
| Return on Equity (ROE) | -54.24% | -64.56% | -34.25% | -67.39% | - | - |
| Return on Assets (ROA) | -33.39% | -40.05% | -21.33% | -28.77% | -1483.59% | - |
| Return on Capital (ROIC) | -35.50% | -42.49% | -22.28% | -32.13% | - | - |
| Earnings Yield | -125.41% | -132.35% | -5.84% | -8.38% | - | - |
| FCF Yield | -131.33% | -114.57% | -5.33% | -3.90% | - | - |
| Buyback Yield / Dilution | -13.07% | -11.57% | -309.11% | -544.96% | -19.64% | - |
| Total Shareholder Return | -13.07% | -11.57% | -309.11% | -544.96% | -19.64% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.